Rümeysa Çiftçi

1.1k total citations
43 papers, 776 citations indexed

About

Rümeysa Çiftçi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Rümeysa Çiftçi has authored 43 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Rümeysa Çiftçi's work include Ovarian cancer diagnosis and treatment (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Research Studies (6 papers). Rümeysa Çiftçi is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Research Studies (6 papers). Rümeysa Çiftçi collaborates with scholars based in Türkiye. Rümeysa Çiftçi's co-authors include Senem Karabulut, Leyla Kılıç, Fatma Şen, Faruk Taş, Derya Duranyıldız, Faruk Taş, Murat Serilmez, Adnan Aydıner, Serkan Keskın and İbrahim Yıldız and has published in prestigious journals such as Journal of Clinical Oncology, Medicine and Cytokine.

In The Last Decade

Rümeysa Çiftçi

38 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rümeysa Çiftçi Türkiye 16 385 249 140 136 134 43 776
Marcella Occelli Italy 15 353 0.9× 176 0.7× 101 0.7× 226 1.7× 141 1.1× 29 691
Roberto Díaz United States 19 353 0.9× 321 1.3× 113 0.8× 131 1.0× 217 1.6× 57 1.0k
Nezih Meydan Türkiye 15 323 0.8× 184 0.7× 88 0.6× 130 1.0× 105 0.8× 44 639
Reinhilde Weytjens Belgium 8 337 0.9× 161 0.6× 143 1.0× 51 0.4× 254 1.9× 18 719
Farzin Khosrow‐Khavar Canada 11 248 0.6× 171 0.7× 54 0.4× 171 1.3× 84 0.6× 37 730
Daniel A. Zlotoff United States 19 604 1.6× 170 0.7× 58 0.4× 412 3.0× 267 2.0× 48 1.5k
Luciano Canobbio Italy 19 512 1.3× 190 0.8× 161 1.1× 70 0.5× 165 1.2× 53 812
E. Cohen United States 16 189 0.5× 323 1.3× 123 0.9× 65 0.5× 195 1.5× 43 1.1k
Leslie Oleksowicz United States 17 236 0.6× 96 0.4× 61 0.4× 98 0.7× 138 1.0× 35 780
Hannah Gilman United States 11 485 1.3× 154 0.6× 36 0.3× 393 2.9× 104 0.8× 22 792

Countries citing papers authored by Rümeysa Çiftçi

Since Specialization
Citations

This map shows the geographic impact of Rümeysa Çiftçi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rümeysa Çiftçi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rümeysa Çiftçi more than expected).

Fields of papers citing papers by Rümeysa Çiftçi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rümeysa Çiftçi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rümeysa Çiftçi. The network helps show where Rümeysa Çiftçi may publish in the future.

Co-authorship network of co-authors of Rümeysa Çiftçi

This figure shows the co-authorship network connecting the top 25 collaborators of Rümeysa Çiftçi. A scholar is included among the top collaborators of Rümeysa Çiftçi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rümeysa Çiftçi. Rümeysa Çiftçi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Çiftçi, Rümeysa, et al.. (2018). Relationship between interleukin-17A and isolated coronary ectasia. Cytokine. 115. 84–88. 5 indexed citations
3.
Koçoğlu, Hakan, Deniz Tural, Yıldız Okuturlar, et al.. (2018). Hepatitis B and C rates are significantly increased in certain solid tumors: A large retrospective study. Journal of Cancer Research and Therapeutics. 14(10). 774–774. 13 indexed citations
4.
5.
Şen, Fatma, Makbule Tambaş, Rümeysa Çiftçi, et al.. (2015). Factors affecting progression-free survival in non-HIV-related Kaposi sarcoma. Journal of Dermatological Treatment. 27(3). 275–277. 3 indexed citations
6.
Karabulut, Senem, Faruk Taş, Didem Taştekin, et al.. (2014). The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer. Tumor Biology. 35(9). 8849–8860. 18 indexed citations
7.
Karabulut, Senem, Faruk Taş, Rümeysa Çiftçi, et al.. (2014). Is there any diagnostic value of serum protease-activated receptor-1 (PAR1) levels on determination of epithelial ovarian carcinoma?. Tumor Biology. 35(5). 4323–4329. 4 indexed citations
8.
Yıldız, İbrahim, Fatma Şen, Leyla Kılıç, Rümeysa Çiftçi, & Mert Başaran. (2014). Intolerance to Sunitinib Treatment in Hemodialysis Patients With Metastatic Renal Cell Carcinoma. Korean journal of urology. 55(1). 74–74. 3 indexed citations
9.
Taş, Faruk, Senem Karabulut, Rümeysa Çiftçi, et al.. (2014). Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy. Cancer Chemotherapy and Pharmacology. 73(6). 1163–1171. 47 indexed citations
10.
Aydıner, Adnan, Rümeysa Çiftçi, Senem Karabulut, & Leyla Kılıç. (2013). Does Beta-blocker Therapy Improve the Survival of Patients with Metastatic Non-small Cell Lung Cancer?. Asian Pacific Journal of Cancer Prevention. 14(10). 6109–6114. 42 indexed citations
11.
Taş, Faruk, Rümeysa Çiftçi, Nesimi Bűyúkbabani, & Senem Karabulut. (2013). Recurrent Gastric Cancer Presenting with Both Scrotal and Facial Skin Metastases: A Case Report. Journal of Gastrointestinal Cancer. 45(1). 96–99.
12.
Taş, Faruk, Senem Karabulut, Elif Bilgin, et al.. (2013). Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma. Tumor Biology. 34(6). 3529–3536. 5 indexed citations
13.
Taş, Faruk, Rümeysa Çiftçi, Leyla Kılıç, et al.. (2013). Clinical and Prognostic Significance of Coagulation Assays in Gastric Cancer. Journal of Gastrointestinal Cancer. 44(3). 285–292. 80 indexed citations
14.
Taş, Faruk, Senem Karabulut, Murat Serilmez, et al.. (2013). Clinical significance of serum M30 and M65 levels in melanoma. Melanoma Research. 23(5). 390–395. 3 indexed citations
15.
Aykan, Nuri Faruk, İbrahim Yıldız, Fatma Şen, et al.. (2013). Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy. Medical Oncology. 30(3). 679–679. 23 indexed citations
16.
Taş, Faruk, Rümeysa Çiftçi, Leyla Kılıç, & Senem Karabulut. (2013). Age is a prognostic factor affecting survival in lung cancer patients. Oncology Letters. 6(5). 1507–1513. 105 indexed citations
17.
Taş, Faruk, Senem Karabulut, Murat Serilmez, Rümeysa Çiftçi, & Derya Duranyıldız. (2013). Clinical significance of serum transforming growth factor-beta 1 (TGF-β1) levels in patients with epithelial ovarian cancer. Tumor Biology. 35(4). 3611–3616. 13 indexed citations
18.
Elitok, Ali, Fahrettin Öz, Ahmet Yaşar Çizgici, et al.. (2013). Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: A prospective randomized controlled study with six-month follow-up. Cardiology Journal. 21(5). 509–515. 97 indexed citations
19.
Taş, Faruk, Rümeysa Çiftçi, Leyla Kılıç, et al.. (2012). Clinical and prognostic significance of coagulation assays in melanoma. Melanoma Research. 22(5). 368–375. 15 indexed citations
20.
Taş, Faruk, Leyla Kılıç, Elif Bilgin, et al.. (2012). Clinical and Prognostic Significance of Coagulation Assays in Advanced Epithelial Ovarian Cancer. International Journal of Gynecological Cancer. 23(2). 276–281. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcella Occelli Breakdown of academic impact, for papers by Roberto Díaz Breakdown of academic impact, for papers by Nezih Meydan Breakdown of academic impact, for papers by Reinhilde Weytjens Breakdown of academic impact, for papers by Farzin Khosrow‐Khavar Breakdown of academic impact, for papers by Daniel A. Zlotoff Breakdown of academic impact, for papers by Luciano Canobbio Breakdown of academic impact, for papers by E. Cohen Breakdown of academic impact, for papers by Leslie Oleksowicz Breakdown of academic impact, for papers by Hannah Gilman
Rankless by CCL
2026